Pancreatic Tubular Adenocarcinoma Clinical Trial
Official title:
Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01021800 -
Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma
|
Phase 2 |